Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 2,266,934 | 2,266,934 | 0 | $38.56M | $55.02M | 67.66% | +$16.46M |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 1,008,116 | +1,008,116 | $0 | $16.37M | 20.13% | +$16.37M |
| Prime Medicine, Inc.(PRME) | 1,792,210 | 1,792,210 | 0 | $4.43M | $9.93M | 12.21% | +$5.50M |
| Lyell Immunopharma, Inc.(LYEL) | 1,008,116 | 0 | -1,008,116 | $8.91M | $0 | — | -$8.91M |